[1]
Dar, M.M., Gulzar, W., Paray, A.A. and Javid, M.S. 2026. Metabolic, neurological and endocrine safety profiles of atypical antipsychotics: focus on quetiapine, olanzapine and risperidone: an updated review. International Journal of Research in Medical Sciences. 14, 4 (Mar. 2026), 1738–1749. DOI:https://doi.org/10.18203/2320-6012.ijrms20260997.